Mohammad Hirmand's Net Worth
$3.9 Million
Who is Mohammad Hirmand?
Mohammad Hirmand has an estimated net worth of $3.9 Million. This is based on reported shares across multiple companies, which include Aadi Bioscience, Inc., Turning Point Therapeutics, Inc., and MEDIVATION, INC..
SEC CIK
Mohammad Hirmand's CIK is 0001654482
Past Insider Trading and Trends
2016 was Mohammad Hirmand's most active year for acquiring shares with 6 total transactions. Mohammad Hirmand's most active month to acquire stocks was the month of January. 2016 was Mohammad Hirmand's most active year for disposing of shares, totalling 16 transactions. Mohammad Hirmand's most active month to dispose stocks was the month of August. 2021 saw Mohammad Hirmand paying a total of $547,300.00 for 45,658 shares, this is the most they've acquired in one year. In 2022 Mohammad Hirmand cashed out on 308,687 shares for a total of $3,161,868.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aadi Bioscience, Inc. (AADI) Snapshot price: $1.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Turning Point Therapeutics, Inc. No price found
EVP and Chief Medical OfficerMohammad Hirmand used to own units in Common Stock but no longer holds any shares there. In the year 2022 Mohammad Hirmand filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -41.28K |
$76.00 | -$3,137,584.00 |
0
|
Aug 17
| |||
Form 4
| +443.77% | 33.31K |
$36.30 | -$24,284.70 | 40.82K |
Feb 9
| |||
Form 4
| +2,282.75% | 6.48K |
—
|
—
| 6.77K |
Feb 8
| |||
Form 4
| -51.37% | -300.00 |
$87.58 | -$693,105.74 | 284 |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MEDIVATION, INC. No price found
Interim Chief Medical OfficerMohammad Hirmand used to own units in Common Stock but no longer holds any shares there. In the year 2015 Mohammad Hirmand acquired a total of 28,610 shares in MEDIVATION, INC. at a cost of $78,522.50, Mohammad also disposed a total of 60,584 shares of MEDIVATION, INC. equalling to $119,061.63.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -57.75K |
—
|
—
|
0
|
Sep 28
| |||
Form 4
| +43.94% | 17.56K |
$4.47 | $78,522.50 | 57.52K |
Sep 15
| |||
Form 4
| +1.41% | 560 |
—
|
—
| 40.24K |
Apr 6 - Apr 8
| |||
Form 4
| -3.73% | -1.52K |
$41.10 | -$62,684.67 | 39.34K |
Mar 4
| |||
Form 4
| +29.89% | 9.3K |
—
|
—
| 40.41K |
Feb 18 - Feb 29
| |||
Form 4
| -3.34% | -1.07K |
$43.40 | -$46,655.00 | 31.11K |
Dec 3
| |||
Form 4
| -0.72% | -232.00 |
$41.91 | -$9,721.96 | 32.19K |
Nov 9
| |||
Form 4
| +3.81% | 1.19K |
—
|
—
| 32.42K |
Sep 29 - Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||